Global Transdermal Drug Delivery System Market Professional Survey Report 2019

In this report,in the last several years, global market of Transdermal Drug Delivery System developed rapidly, with an average sales growth rate of 13.4%. In 2016, global revenue of Transdermal Drug Delivery System was nearly 8000 million USD; the actual production is about 13300 million units.

Transdermal Drug Delivery System is a medicated adhesive patch that is placed on the skin to deliver a specific dose of medication through the skin and into the bloodstream. Often, this promotes healing to an injured area of the body. The unprecedented global shift in the adoption of unhealthy lifestyles is to be responsible for the high prevalence of chronic diseases, such as cancer and diabetes, which is expected to drive the clinical urgency to incorporate transdermal drug delivery systems in the future treatments. Moreover, the rising geriatric population base, which is highly susceptible to developing the aforementioned chronic diseases are expected to propel the demand for highly efficacious pharmacological drugs.

The classification of Transdermal Drug Delivery System includes Fentanyl, Nitroglycerin, Estradiol, Nicotine and Other, and the revenue proportion of Fentanyl in 2016 was about 31%.

Transdermal Drug Delivery System can be used for OTC and Rx. The most proportion of Transdermal Drug Delivery System is OTC, and the sales proportion was about 83% in 2016.

Market competition is intense. Hisamitsu, Mylan, Johnson & Johnson, Actavis, etc. are the leaders of the industry.

North America was the largest sales place, with revenue market share nearly 41% in 2016. Following North America, Europe is the second largest sales place. China and Japan are also important sales regions for Transdermal Drug Delivery System.

This report focuses on top manufacturers in global market, Involved the assessment of Sales, price, revenue and market share for each manufacturer, covering
Hisamitsu
Mylan
GSK
Novartis
Teve (Actavis)
Johnson & Johnson
UCB
Teikoku Seiyaku
Bayer
Lingrui
Sanofi
Qizheng
Endo
Huarun 999
Haw Par
Nichiban
Mentholatum Company
Laboratoires Genevrier
Other
...

On the basis of product, this report displays the Sales, revenue, price, market share and growth rate of each type, primarily split into
Fentanyl
Nitroglycerin
Estradiol
Nicotine
Other

By Application, this report focuses on Sales, Market share and Growth Rate of each application, can be divided into
OTC
Rx

By Regions, this report splits global market into several key regions, with Sales, Revenue, Price and Gross Margin market share of top players in these regions, from 2014 to 2026 (forecast), like
China
USA
Europe
Japan
Korea
India
Southeast Asia
South America

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

Global Transdermal Drug Delivery System Market Professional Survey Report 2019
1 Report Overview
1.1 Definition and Specification
1.2 Manufacturers and Region Overview
1.2.1 Manufacturers Overview
1.2.2 Regions Overview
1.3 Type Overview
1.3.1 Fentanyl
1.3.2 Nitroglycerin
1.3.3 Estradiol
1.3.4 Nicotine
1.3.5 Other
1.4 Application Overview
1.4.1 OTC
1.4.2 Rx
1.5 Industrial Chain
1.5.1 Transdermal Drug Delivery System Industrial Chain
1.5.2 Upstream
1.5.3 Downstream
2.1 The Overall Market Performance(Volume)
2.1.1 Fentanyl
2.1.2 Nitroglycerin
2.1.3 Estradiol
2.1.4 Nicotine
2.1.5 Other
2.2 The Overall Market Performance(Value)
2.2.1 Fentanyl
2.2.2 Nitroglycerin
2.2.3 Estradiol
2.2.4 Nicotine
2.2.5 Other
3 Global Transdermal Drug Delivery System Market Assessment by Application
3.1 Overall Market Performance (Volume)
3.2 OTC
3.3 Rx
4 Competitive Analysis
4.1 Hisamitsu
4.1.1 Hisamitsu Profiles
4.1.2 Hisamitsu Product Information
4.1.3 Hisamitsu Transdermal Drug Delivery System Business Performance
4.1.4 SWOT Analysis
4.2 Mylan
4.2.1 Mylan Profiles
4.2.2 Mylan Product Information
4.2.3 Mylan Transdermal Drug Delivery System Business Performance
4.2.4 SWOT Analysis
4.3 GSK
4.3.1 GSK Profiles
4.3.2 GSK Product Information
4.3.3 GSK Transdermal Drug Delivery System Business Performance
4.3.4 SWOT Analysis
4.4 Novartis
4.4.1 Novartis Profiles
4.4.2 Novartis Product Information
4.4.3 Novartis Transdermal Drug Delivery System Business Performance
4.4.4 SWOT Analysis
4.5 Teve (Actavis)
4.5.1 Teve (Actavis) Profiles
4.5.2 Teve (Actavis) Product Information
4.5.3 Teve (Actavis) Transdermal Drug Delivery System Business Performance
4.5.4 SWOT Analysis
4.6 Johnson & Johnson
4.6.1 Johnson & Johnson Profiles
4.6.2 Johnson & Johnson Product Information
4.6.3 Johnson & Johnson Transdermal Drug Delivery System Business Performance
4.6.4 SWOT Analysis
4.7 UCB
4.7.1 UCB Profiles
4.7.2 UCB Product Information
4.7.3 UCB Transdermal Drug Delivery System Business Performance
4.7.4 SWOT Analysis
4.8 Teikoku Seiyaku
4.8.1 Teikoku Seiyaku Profiles
4.8.2 Teikoku Seiyaku Product Information
4.8.3 Teikoku Seiyaku Transdermal Drug Delivery System Business Performance
4.8.4 SWOT Analysis
4.9 Bayer
4.9.1 Bayer Profiles
4.9.2 Bayer Product Information
4.9.3 Bayer Transdermal Drug Delivery System Business Performance
4.9.4 SWOT Analysis
4.10 Lingrui
4.10.1 Lingrui Profiles
4.10.2 Lingrui Product Information
4.10.3 Lingrui Transdermal Drug Delivery System Business Performance
4.10.4 SWOT Analysis
4.11 Sanofi
4.12 Qizheng
4.13 Endo
4.14 Huarun 999
4.15 Haw Par
4.16 Nichiban
4.17 Mentholatum Company
4.18 Laboratoires Genevrier
4.19 Other
5 Competitive Lanscape
5.1 Global Transdermal Drug Delivery System Capacity (K Units) and Market Share of Manufacturers (2014-2020)
5.2 Global Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
5.3 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
5.4 Global Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
5.5 Global Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
5.6 Market Concentration
6 Regional Market Analysis
6.1 China Market Performance for Manufacturers
6.1.1 China Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.1.2 China Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.1.3 China Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.1.4 China Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.1.5 Market Concentration
6.2 USA Market Performance for Manufacturers
6.2.1 USA Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.2.2 USA Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.2.3 USA Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.2.4 USA Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.2.5 Market Concentration
6.3 Europe Market Performance for Manufacturers
6.3.1 Europe Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.3.2 Europe Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.3.3 Europe Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.3.4 Europe Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.3.5 Market Concentration
6.4 Japan Market Performance for Manufacturers
6.4.1 Japan Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.4.2 Japan Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.4.3 Japan Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.4.4 Japan Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.4.5 Market Concentration
6.5 Korea Market Performance for Manufacturers
6.5.1 Korea Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.5.2 Korea Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.5.3 Korea Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.5.4 Korea Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.5.5 Market Concentration
6.6 India Market Performance for Manufacturers
6.6.1 India Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.6.2 India Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.6.3 India Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.6.4 India Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.6.5 Market Concentration
6.7 Southeast Asia Market Performance for Manufacturers
6.7.1 Southeast Asia Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.7.2 Southeast Asia Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.7.3 Southeast Asia Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.7.4 Southeast Asia Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.7.5 Market Concentration
6.8 South America Market Performance for Manufacturers
6.8.1 South America Transdermal Drug Delivery System Sales (K Units) and Market Share of Manufacturers (2014-2020)
6.8.2 South America Transdermal Drug Delivery System Revenue (M USD) and Market Share of Manufacturers (2014-2020)
6.8.3 South America Transdermal Drug Delivery System Price (USD/Unit) of Manufacturers (2014-2020)
6.8.4 South America Transdermal Drug Delivery System Gross Margin of Manufacturers (2014-2020)
6.8.5 Market Concentration
7 Global Transdermal Drug Delivery System Market Assessment by Regions
7.1 Global Transdermal Drug Delivery System Capacity (K Units) and Market Share by Regions (2014-2020)
7.2 Global Transdermal Drug Delivery System Sales (K Units) and Market Share by Regions (2014-2020)
7.3 Global Transdermal Drug Delivery System Revenue (M USD) and Market Share by Regions (2014-2020)
7.4 Global Transdermal Drug Delivery System Price (USD/Unit) by Regions (2014-2020)
7.5 Global Transdermal Drug Delivery System Gross Margin by Regions (2014-2020)
8 Capacity Analysis of Different Regions
8.1 Global Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.2 China Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.3 USA Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.4 Europe Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.5 Japan Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.6 Korea Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.7 India Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.8 Southeast Asia Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
8.9 South America Transdermal Drug Delivery System Capacity and Growth Rate (2014-2020)
9 Technology and Cost Analysis
9.1 Technology
9.2 Cost
10 Channel Analysis
10.1 Market Channel
10.2 Manufacturing Plants Distribution of Global Transdermal Drug Delivery System Major Manufacturers
11 Global Transdermal Drug Delivery System Market Forecast by Regions
11.1 Global Transdermal Drug Delivery System Market Forecast (2021-2026)
11.1.1 Global Transdermal Drug Delivery System Capacity Forecast by Regions (2021-2026)
11.1.2 Global Transdermal Drug Delivery System Sales Forecast by Regions (2021-2026)
11.1.2 Global Transdermal Drug Delivery System Revenue Forecast by Regions (2021-2026)
11.2 China Transdermal Drug Delivery System Market Forecast (2021-2026)
11.3 USA Transdermal Drug Delivery System Market Forecast (2021-2026)
11.4 Europe Transdermal Drug Delivery System Market Forecast (2021-2026)
11.5 Japan Transdermal Drug Delivery System Market Forecast (2021-2026)
11.6 Korea Transdermal Drug Delivery System Market Forecast (2021-2026)
11.7 India Transdermal Drug Delivery System Market Forecast (2021-2026)
11.8 Southeast Asia Transdermal Drug Delivery System Market Forecast (2021-2026)
11.9 South America Transdermal Drug Delivery System Market Forecast (2021-2026)
12 Global Transdermal Drug Delivery System Market Forecast by Types (2021-2026)
12.1 Overall Market Performance (Sales, Revenue)
12.2 Fentanyl
12.3 Nitroglycerin
12.4 Estradiol
12.5 Nicotine
12.6 Other
13 Global Transdermal Drug Delivery System Market Forecast by Application (2021-2026)
13.1 Overall Market Performance (Sales and Growth Rate)
13.2 OTC
13.3 Rx
14 Global Price (USD/Unit) and Gross Profit Forecast
14.1 Global Transdermal Drug Delivery System Average Price Forecast (2021-2026)
14.2 Global Transdermal Drug Delivery System Gross Profit Forecast (2021-2026)
15 Conclusion